BELLEVUE, Wash. and LA JOLLA, Calif., July 14, 2025 /PRNewswire/ -- Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...
miRecule’s NAVIgGator platform will be combined with RBBL’s capabilities in peptide development and manufacturing. Credit: Gorodenkoff / Shutterstock.com. · Pharmaceutical Technology · Gorodenkoff / ...
Hosted on MSN
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...
GERMANTOWN, MD and HOUSTON, TX, December 9, 2025 (Newswire.com) - uBriGene Biosciences, a global CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development and manufacturing, today ...
(From left) Mr Beh Kian Teik, CEO, Agency for Science, Technology and Research (A*STAR); Prof Tan Chorh Chuan, Permanent Secretary (National Research and Development), Singapore Prime Minister’s ...
A new liquid biopsy developed by researchers at the University of Chicago is offering a powerful new window into cancer’s earliest stages by flagging subtle shifts in the gut microbiome. Unlike ...
The MarketWatch News Department was not involved in the creation of this content. First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results